Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Return on Sales [ROS] (2017 - 2022)

Updated

Vitaspring Biomedical (VSBC) recorded Return on Sales [ROS] of 28.22% in fiscal Q3 2023 (quarter ended Oct 31, 2022), down 40.51 percentage points from 68.73% a year earlier and down 5.10 percentage points from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Return on Sales [ROS] (2017 - 2022) Analysis & Trends

For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical reported Return on Sales [ROS] of 20.07%, up 191.46 percentage points from FY2021.

  • Annual Return on Sales [ROS] has a four-year change of +59.34 percentage points (FY2018 to FY2022).
  • Across earlier fiscal years, Return on Sales [ROS] came in at -171.39% in FY2021 (-217.09 pp), 45.70% in FY2020 (+176.06 pp), -130.36% in FY2019 (-91.09 pp) and -39.27% in FY2018.
  • Quarterly Return on Sales [ROS] has ranged from -17402.67% in fiscal Q3 2019 to 2631.75% in fiscal Q4 2019 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in six of the last eight quarters, with an average year-over-year change of +896.34 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 17615.70 percentage points in fiscal Q3 2020, against a drop of 17396.48 percentage points in fiscal Q3 2019 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at 33.32% (Q2 2023), 23.03% (Q1 2023) and 40.68% (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2022 28.22%
Jul 31, 2022 33.32%
Apr 30, 2022 23.03%
Jan 31, 2022 40.68%
Oct 31, 2021 68.73%
Jul 31, 2021 18.04%
Apr 30, 2021 33.61%
Jan 31, 2021 -139.29%
Oct 31, 2020 -3,689.77%
Jul 31, 2020 -2,950.91%
Apr 30, 2020 -812.43%
Jan 31, 2020 -141.62%
Oct 31, 2019 533.04%
Jul 31, 2019 423.99%
Apr 30, 2019 -117.95%
Jan 31, 2019 2,631.75%
Oct 31, 2018 -17,402.67%
Jul 31, 2018 -598.45%
Apr 30, 2018 39.99%
Jan 31, 2018 1,911.39%
API Access

Vitaspring Biomedical Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEY